|   | 
SU9516
                            - 英文名称:SU9516
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11589
- cas:377090-84-1
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-10-31
产品详请
            | 产地 | 进口 | 
| 品牌 | WYTSCI | 
| 货号 | WT-AY-B11589 | 
| 用途 | 科研检测 | 
| 英文名称 | SU9516 | 
| 包装规格 | 1MG | 
| CAS编号 | 377090-84-1 | 
| 别名 | SU9516 | 
| 纯度 | 98+% | 
| 分子式 | |
| 是否进口 | 是 | 
                纯度:>98% by HPLC;NMR (Conforms)
分子式:C13H11N3O2
分子量:241.25
溶剂:DMSO (25 mg/ml)
性状:Orange solid
存储:-20°C
Activity (short version):CDK inhibitor (pan-specific)
Function / Pharmacology:Cyclin-dependent kinase inhibitor, IC50s= 0.02-0.03, 0.04-0.2, 0.2-1.7 and 0.9 μM for cdk2, cdk1, cdk4, cdk9 respectively.1,2 Inhibits phosphorylation of retinoblastoma protein pRb, causing enhanced pRb/E2f complex formation, cell cycle arrest at G1 and G2-M and apoptosis.3 Down-regulates antiapoptotic protein Mcl-1 expression resulting in mitochondrial injury and cell death.4 Inhibits epithelial-mesenchymal transition (IC50=1.21 μM) a crucial pathological event in tumor cell budding and metastasis.5 Cell permeable.
            
        分子式:C13H11N3O2
分子量:241.25
溶剂:DMSO (25 mg/ml)
性状:Orange solid
存储:-20°C
Activity (short version):CDK inhibitor (pan-specific)
Function / Pharmacology:Cyclin-dependent kinase inhibitor, IC50s= 0.02-0.03, 0.04-0.2, 0.2-1.7 and 0.9 μM for cdk2, cdk1, cdk4, cdk9 respectively.1,2 Inhibits phosphorylation of retinoblastoma protein pRb, causing enhanced pRb/E2f complex formation, cell cycle arrest at G1 and G2-M and apoptosis.3 Down-regulates antiapoptotic protein Mcl-1 expression resulting in mitochondrial injury and cell death.4 Inhibits epithelial-mesenchymal transition (IC50=1.21 μM) a crucial pathological event in tumor cell budding and metastasis.5 Cell permeable.

 
     
            
            
            
              
             

